View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
Morten Jensen
  • Morten Jensen
Free Trial
HOLMB SS HOLMEN

Discontinuing coverage

Discontinuing coverage We have discontinued coverage of Holmen. Our last recommendation, target price, and estimates should not be relied upon going forward.

10/03/17 October 3, 2017 8 EN
Free Trial
HOLMB SS HOLMEN

Much as expected

Holmen’s Q2 did not provide any major surprises. Sales delivered a 7% consensus beat, but costs were higher as well, resulting in adjusted EBIT of SEK525m, very close to consensus expectations. The Forest value gain was SEK102m, a relatively high number. We expect limited changes to consensus estimates. The shares should trade sideways for the rest of the session.

08/17/17 August 17, 2017 9 EN
Free Trial
HOLMB SS HOLMEN

Aligned with consensus into Q2

Holmen (HOLMB SS, Sell) - Aligned with consensus into Q2 (15 pages)

08/03/17 August 3, 2017 15 EN
Free Trial
HOLMB SS HOLMEN

Operations as expected

Holmen (HOLMB SS, Sell) - (16 pages)

05/03/17 May 3, 2017 16 EN
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch